Cellectis SA (CLLS)
1.61
+0.02
(+1.26%)
USD |
NASDAQ |
Dec 20, 16:00
1.58
-0.03
(-1.86%)
After-Hours: 20:00
Cellectis Total Assets (Quarterly): 395.88M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Edap TMS SA | 88.28M |
| DBV Technologies SA | 93.06M |
| Genfit SA | 192.20M |
| Akari Therapeutics PLC | 2.734M |
| Biodexa Pharmaceuticals PLC | 17.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 266.45M |
| Shareholders Equity (Quarterly) | 129.42M |
| Debt to Equity Ratio | 0.3579 |
| Current Ratio | 1.777 |
| Net Debt Paydown Yield | -1.21% |